Sodium in PDB 6tx9: Crystal Structure of Human FKBP51 FK1 Domain A19T Mutant in Complex with Hydantoin

All present enzymatic activity of Crystal Structure of Human FKBP51 FK1 Domain A19T Mutant in Complex with Hydantoin:
5.2.1.8;

The structure of Crystal Structure of Human FKBP51 FK1 Domain A19T Mutant in Complex with Hydantoin, PDB code: 6tx9 was solved by D.Fiegen, S.W.Draxler, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	16.45 / 1.42
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	42.233, 54.418, 56.730, 90.00, 90.00, 90.00
R / Rfree (%)	16.2 / 18.7

The binding sites of Sodium atom in the Crystal Structure of Human FKBP51 FK1 Domain A19T Mutant in Complex with Hydantoin (pdb code 6tx9). This binding sites where shown within 5.0 Angstroms radius around Sodium atom.
In total 2 binding sites of Sodium where determined in the Crystal Structure of Human FKBP51 FK1 Domain A19T Mutant in Complex with Hydantoin, PDB code: 6tx9:
Jump to Sodium binding site number: 1; 2;

Sodium binding site 1 out of 2 in the Crystal Structure of Human FKBP51 FK1 Domain A19T Mutant in Complex with Hydantoin


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 1 of Crystal Structure of Human FKBP51 FK1 Domain A19T Mutant in Complex with Hydantoin within 5.0Å range: probe atom residue distance (Å) B Occ A:Na202 b:21.8 occ:1.00 O A:HOH412 2.9 28.5 1.0 CG2 A:THR17 3.6 13.2 1.0 OG1 A:THR17 4.1 14.0 1.0 NZ A:LYS38 4.1 14.7 1.0 CB A:THR17 4.1 12.6 1.0 O A:HOH397 4.9 14.8 1.0

Sodium binding site 2 out of 2 in the Crystal Structure of Human FKBP51 FK1 Domain A19T Mutant in Complex with Hydantoin


Mono view


Stereo pair view

A full contact list of Sodium with other atoms in the Na binding site number 2 of Crystal Structure of Human FKBP51 FK1 Domain A19T Mutant in Complex with Hydantoin within 5.0Å range: probe atom residue distance (Å) B Occ A:Na203 b:27.9 occ:1.00 O A:HOH457 2.6 20.1 0.6 OE1 A:GLU101 2.7 13.6 1.0 O A:THR96 2.7 15.7 1.0 NZ A:LYS98 3.0 29.5 0.4 NZ A:LYS98 3.2 27.5 0.6 CD A:LYS98 3.3 21.5 0.4 NZ A:LYS35 3.4 9.3 1.0 CD A:GLU101 3.5 12.9 1.0 OE2 A:GLU101 3.6 12.9 1.0 O A:HOH400 3.7 21.5 1.0 CE A:LYS98 3.7 24.7 0.4 O A:HOH374 3.7 28.3 1.0 C A:THR96 3.8 13.6 1.0 O A:HOH369 4.0 18.5 1.0 CA A:MET97 4.1 11.4 1.0 O A:HOH467 4.2 25.9 1.0 N A:LYS98 4.2 13.1 0.6 N A:LYS98 4.2 12.4 0.4 CG A:LYS98 4.2 18.2 0.6 CE A:LYS98 4.4 28.3 0.6 N A:MET97 4.4 12.1 1.0 CD A:LYS98 4.4 23.8 0.6 C A:MET97 4.4 13.3 1.0 CG2 A:VAL37 4.5 16.1 1.0 CG A:LYS98 4.7 18.4 0.4 CE A:LYS35 4.7 12.8 1.0 CG A:GLU101 4.9 12.3 1.0 CB A:LYS98 4.9 13.8 0.6 OG1 A:THR96 5.0 12.0 1.0 CB A:THR96 5.0 12.9 1.0 CA A:THR96 5.0 11.5 1.0

S.W.Draxler, M.Bauer, C.Eickmeier, S.Nadal, H.Nar, D.Rangel, D.Seeliger, M.Zeeb, D.Fiegen. A Hybrid Screening Approach For Very Small Fragments - X-Ray and Computational Screening on FKBP51. J.Med.Chem. 2020.
ISSN: ISSN 0022-2623
PubMed: 32420743
DOI: 10.1021/ACS.JMEDCHEM.0C00120